InvestorsHub Logo
Followers 45
Posts 4299
Boards Moderated 0
Alias Born 09/01/2017

Re: ATLnsider post# 509653

Wednesday, 08/31/2022 9:40:07 AM

Wednesday, August 31, 2022 9:40:07 AM

Post# of 698811
The CRL PR does mention dendritic cell immunotherapy products in a secondary nature to the subject of the PR.

So I think nwbo still can be a customer of CRL for DCVAX production if/when needed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News